Fabino Enterprises appoints three additional directors

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Fabino Enterprises Ltd appointed Samrat Vardhan Dutta as Non-Executive Director
  • Sarthak Goyal appointed as Executive Director in Promoter category
  • Rahul Mangla appointed as Independent Director effective September 29, 2026
  • All appointments hold office until the conclusion of the ensuing AGM
powered bylight_fuzz_icon
52245088

*this image is generated using AI for illustrative purposes only.

Fabino Enterprises Ltd has expanded its board of directors with the appointment of three new members during a meeting held on September 29, 2026. The board approved the inclusion of Samrat Vardhan Dutta, Sarthak Goyal, and Rahul Mangla, covering non-executive, executive promoter, and independent director roles respectively.

The appointments were made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Each director will hold office until the conclusion of the ensuing Annual General Meeting. The board meeting commenced at 5:00 pm and concluded at 5:30 pm.

Director profiles and categories

The company disclosed detailed profiles for each appointee in compliance with SEBI master circulars dated November 11, 2024, and January 30, 2026.

Name Category Background Highlights
Samrat Vardhan Dutta Non-Executive Entrepreneur with expertise in D2C, marketing, consumer behavior, sales, and technology. Holds a bachelor's degree in business administration from Emirates Academy of Hospitality Management, Dubai.
Sarthak Goyal Executive (Promoter) Entrepreneur with experience in biofuel, renewable energy, investment, and diversified business sectors. Holds a BBA from Emirates Academy, Dubai, and completed a short-term course in Economics from Harvard Business School.
Rahul Mangla Independent Advocate practicing since 2010. Specializes in debt recovery, medical negligence, financial disputes, RERA matters, and corporate advisory on mergers and amalgamations. Has appeared before NCLT and Enforcement Directorate.

Regulatory disclosures

All three appointees have confirmed they are not debarred from holding the office of directors by any order passed by the Securities and Exchange Board of India or any other authority. The appointments were recommended by the Nomination and Remuneration Committee.

Fabino Enterprises Limited is an ISO 9001:2015 certified company formerly known as Fabino Life Sciences Ltd. The company is listed on the BSE.

Historical Stock Returns for Fabino Enterprises

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%0.0%0.0%0.0%-49.67%

How will the addition of expertise in biofuel and renewable energy under the new executive promoter potentially pivot Fabino Enterprises' strategic direction away from its former life sciences identity?

What specific corporate governance improvements are expected from the appointment of an independent director with specialized experience in NCLT proceedings and debt recovery?

Given the short tenure until the ensuing AGM, what key strategic initiatives or financial disclosures are likely to be prioritized by the newly expanded board in the interim period?

Fabino Enterprises adopts FY26 financials at 15th AGM

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Fabino Enterprises held its 15th AGM on September 29, 2026
  • Members adopted standalone and consolidated FY26 financial statements
  • Auditor reports for FY26 contained no qualifications or adverse comments
  • Special resolution approved for disposal of business via subsidiary shares
powered bylight_fuzz_icon
52229845

*this image is generated using AI for illustrative purposes only.

Fabino Enterprises Ltd held its 15th Annual General Meeting on September 29, 2026, through Video Conferencing. The meeting focused on adopting the standalone and consolidated financial statements for the year ended March 31, 2026.

The company, formerly known as Fabino Life Sciences Limited, reported that the Statutory Auditors and Secretarial Auditor issued clean reports for FY26, with no qualifications or adverse observations affecting the company's functioning. Eight members and six directors attended the virtual meeting, which commenced at 12:30 pm and concluded at 12:56 pm.

Key resolutions passed

Members approved several ordinary and special resolutions during the session. The agenda included the adoption of annual reports, director appointments, auditor re-appointment, and a significant corporate action regarding subsidiary shares.

Agenda Item Resolution Type Status
Adopt Standalone Financial Statements FY26 Ordinary Approved
Adopt Consolidated Financial Statements FY26 Ordinary Approved
Re-appoint Mr. Arihant Jain (retiring by rotation) Ordinary Approved
Re-appoint M/s D G M S & Co. as Statutory Auditors Ordinary Approved
Re-appoint Mrs. Tesu Alakh as Independent Director Special Approved
Regularize Mrs. Deepali Singla as Independent Director Special Approved
Approve sale/disposal of business via subsidiary shares Special Approved

Corporate governance updates

The board recommended the re-appointment of M/s D G M S & Co., Chartered Accountants, as the Statutory Auditors. Additionally, the meeting addressed board composition changes, including the regularization of Mrs. Deepali Singla as a Non-executive Independent Director and the re-appointment of Mrs. Tesu Alakh to the same role.

Mr. Arihant Jain, who retired by rotation, was re-appointed as a director following his eligibility to offer himself for the position. The company noted that remote e-voting facilities were provided by National Securities Depository Limited (NSDL) from September 25, 2026, to September 28, 2026.

Historical Stock Returns for Fabino Enterprises

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%0.0%0.0%0.0%0.0%-49.67%

What specific strategic objectives will Fabino Enterprises pursue with the capital generated from the approved sale or disposal of subsidiary shares?

How might the regularization of Mrs. Deepali Singla as an Independent Director influence the company's governance standards and investor confidence in the coming fiscal year?

Given the company's rebranding from Fabino Life Sciences, what new industry verticals or operational pivots are expected to drive future revenue growth?

More News on Fabino Enterprises

1 Year Returns:0.00%